{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T17:09:34Z","timestamp":1784740174382,"version":"3.55.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T00:00:00Z","timestamp":1695340800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["AAG2549"],"award-info":[{"award-number":["AAG2549"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsurgicalresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Surgical Research"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.jss.2023.09.053","type":"journal-article","created":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T18:48:21Z","timestamp":1697741301000},"page":"82-92","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Preclinical Models of Anal Cancer Combined-Modality Therapy"],"prefix":"10.1016","volume":"294","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6748-5143","authenticated-orcid":false,"given":"Hillary R.","family":"Johnson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura C.","family":"Gunder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amani","family":"Gillette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Sleiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooks L.","family":"Rademacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise M.","family":"Meske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wesley S.","family":"Culberson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Micka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Favreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina A.","family":"Matkowskyj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa C.","family":"Skala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5536-7761","authenticated-orcid":false,"given":"Evie H.","family":"Carchman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jss.2023.09.053_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12029-014-9673-0","article-title":"Shifting paradigm in the management of anal canal carcinoma","volume":"46","author":"Mallick","year":"2015","journal-title":"J Gastrointest Cancer"},{"key":"10.1016\/j.jss.2023.09.053_bib2","doi-asserted-by":"crossref","first-page":"106","DOI":"10.6004\/jnccn.2010.0007","article-title":"Anal carcinoma","volume":"8","author":"Engstrom","year":"2010","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.jss.2023.09.053_bib3","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1200\/JCO.1997.15.5.2040","volume":"15","author":"Bartelink","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jss.2023.09.053_bib4","doi-asserted-by":"crossref","first-page":"e449","DOI":"10.3747\/co.21.1903","article-title":"One compared with two cycles of mitomycin C in chemoradiotherapy for anal cancer: analysis of outcomes and toxicity","volume":"21","author":"Yeung","year":"2014","journal-title":"Curr Oncol"},{"key":"10.1016\/j.jss.2023.09.053_bib5","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.soc.2016.07.004","article-title":"Evolution and management of treatment-related toxicity in anal cancer","volume":"26","author":"Ludmir","year":"2017","journal-title":"Surg Oncol Clin N Am"},{"key":"10.1016\/j.jss.2023.09.053_bib7","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.soc.2016.07.006","article-title":"Locally recurrent disease related to anal canal cancers","volume":"26","author":"Sammour","year":"2017","journal-title":"Surg Oncol Clin N Am"},{"key":"10.1016\/j.jss.2023.09.053_bib8","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/bjs.4908","article-title":"Patterns of local disease failure and outcome after salvage surgery in patients with anal cancer","volume":"92","author":"Renehan","year":"2005","journal-title":"Br J Surg"},{"key":"10.1016\/j.jss.2023.09.053_bib9","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1158\/1940-6207.CAPR-10-0086","article-title":"A mouse model for human anal cancer","volume":"3","author":"Stelzer","year":"2010","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.jss.2023.09.053_bib10","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.ejca.2015.01.058","article-title":"High-sensitivity human papilloma virus genotyping reveals near universal positivity in anal squamous cell carcinoma: different implications for vaccine prevention and prognosis","volume":"51","author":"Baricevic","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jss.2023.09.053_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0164273","article-title":"Dysregulation of autophagy contributes to anal carcinogenesis","volume":"11","author":"Carchman","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jss.2023.09.053_bib12","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1158\/1940-6207.CAPR-10-0228","article-title":"Rapamycin inhibits anal carcinogenesis in two preclinical animal models","volume":"3","author":"Stelzer","year":"2010","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.jss.2023.09.053_bib13","doi-asserted-by":"crossref","first-page":"5376","DOI":"10.1158\/1078-0432.CCR-18-3590","article-title":"Patient-derived cancer organoid cultures to predict sensitivity to chemotherapy and radiation","volume":"25","author":"Pasch","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jss.2023.09.053_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-022-08937-z","article-title":"Impact of baseline culture conditions of cancer organoids when determining therapeutic response and tumor heterogeneity","volume":"12","author":"DeStefanis","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.jss.2023.09.053_bib15","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1158\/1078-0432.CCR-18-2843","article-title":"Activating mutations in Pik3ca contribute to anal carcinogenesis in the presence or absence of HPV-16 oncogenes","volume":"25","author":"Shin","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jss.2023.09.053_bib16","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1093\/annonc\/mdw152","article-title":"Comprehensive genomic profiling of anal squamous cell carcinoma reveals distinct genomically defined classes","volume":"27","author":"Chung","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jss.2023.09.053_bib17","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/CEJ.0000000000000505","article-title":"Topical application of a dual PI3K\/mTOR inhibitor prevents anal carcinogenesis in a human papillomavirus mouse model of anal cancer","volume":"28","author":"Rademacher","year":"2019","journal-title":"Eur J Cancer Prev"},{"key":"10.1016\/j.jss.2023.09.053_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexmp.2022.104752","article-title":"PI3K\/mTOR inhibition prevents anal cancer in mice with established low-grade anal dysplasia","volume":"125","author":"Gunder","year":"2022","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.jss.2023.09.053_bib19","first-page":"4862","article-title":"Dissection of human papillomavirus E6 and E7 function in transgenic mouse models of cervical carcinogenesis","volume":"63","author":"Riley","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.jss.2023.09.053_bib20","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1053\/srao.2003.50002","article-title":"The mechanism of action of radiosensitization of conventional chemotherapeutic agents","volume":"13","author":"Lawrence","year":"2003","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.jss.2023.09.053_bib21","article-title":"Dosimetric characterization and output verification for conical brachytherapy surface applicators. Part I. Electronic brachytherapy source: output verification for surface applicators","volume":"41","author":"Fulkerson","year":"2014","journal-title":"Med Phys"},{"key":"10.1016\/j.jss.2023.09.053_bib22","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.neo.2019.04.004","article-title":"Cellular metabolic heterogeneity in\u00a0vivo is recapitulated in tumor organoids","volume":"21","author":"Sharick","year":"2019","journal-title":"Neoplasia"},{"key":"10.1016\/j.jss.2023.09.053_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fonc.2020.00553","article-title":"Metabolic heterogeneity in patient tumor-derived organoids by primary site and drug treatment","volume":"10","author":"Sharick","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.jss.2023.09.053_bib24","series-title":"An Automated Image Processing Routine for Segmentation of Cell Cytoplasms in High-Resolution Autofluorescence Images","author":"Walsh","year":"2014"},{"key":"10.1016\/j.jss.2023.09.053_bib25","doi-asserted-by":"crossref","first-page":"597","DOI":"10.22237\/jmasm\/1257035100","article-title":"New effect size rules of thumb","volume":"8","author":"Sawilowsky","year":"2009","journal-title":"J Mod Appl Stat Methods"},{"key":"10.1016\/j.jss.2023.09.053_bib26","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3102\/0013189X005010003","article-title":"Primary, secondary, and meta-analysis of research","volume":"5","author":"Glass","year":"1976","journal-title":"Educ Res"},{"key":"10.1016\/j.jss.2023.09.053_bib27","doi-asserted-by":"crossref","DOI":"10.1117\/1.JBO.21.6.060503","article-title":"Correlating two-photon excited fluorescence imaging of breast cancer cellular redox state with seahorse flux analysis of normalized cellular oxygen consumption","volume":"21","author":"Hou","year":"2016","journal-title":"J Biomed Opt"},{"key":"10.1016\/j.jss.2023.09.053_bib28","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1158\/0008-5472.CAN-13-2713","article-title":"Endogenous two-photon fluorescence imaging elucidates metabolic changes related to enhanced glycolysis and glutamine consumption in precancerous epithelial tissues","volume":"74","author":"Varone","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.jss.2023.09.053_bib30","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/ijc.31662","article-title":"Activation of WNT\/\u03b2-catenin signaling results in resistance to a dual PI3K\/mTOR inhibitor in colorectal cancer cells harboring PIK3CA mutations: resistance mechanism of a dual PI3K\/mTOR inhibitor","volume":"144","author":"Park","year":"2019","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jss.2023.09.053_bib31","doi-asserted-by":"crossref","first-page":"6164","DOI":"10.1158\/0008-5472.CAN-13-0527","article-title":"Optical metabolic imaging identifies glycolytic levels, subtypes, and early-treatment response in breast cancer","volume":"73","author":"Walsh","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.jss.2023.09.053_bib32","doi-asserted-by":"crossref","DOI":"10.1117\/1.JBO.26.3.036005","article-title":"Patient-derived cancer organoid tracking with wide-field one-photon redox imaging to assess treatment response","volume":"26","author":"Gil","year":"2021","journal-title":"J Biomed Opt"},{"key":"10.1016\/j.jss.2023.09.053_bib33","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1002\/(SICI)1097-0142(19990415)85:8<1686::AID-CNCR7>3.0.CO;2-7","article-title":"Malignant tumors of the anal canal: the spectrum of disease, treatment, and outcomes","volume":"85","author":"Klas","year":"1999","journal-title":"Cancer"}],"container-title":["Journal of Surgical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480423004882?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480423004882?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:02:34Z","timestamp":1758380554000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022480423004882"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":31,"alternative-id":["S0022480423004882"],"URL":"https:\/\/doi.org\/10.1016\/j.jss.2023.09.053","relation":{},"ISSN":["0022-4804"],"issn-type":[{"value":"0022-4804","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preclinical Models of Anal Cancer Combined-Modality Therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Surgical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jss.2023.09.053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}